vs
STANDARD BIOTOOLS INC.(LAB)与自由媒体集团(OLP)财务数据对比。点击上方公司名可切换其他公司
自由媒体集团的季度营收约是STANDARD BIOTOOLS INC.的1.3倍($24.7M vs $19.6M),自由媒体集团净利率更高(9.7% vs -177.4%,领先187.1%),自由媒体集团同比增速更快(3.7% vs -11.5%),过去两年自由媒体集团的营收复合增速更高(4.4% vs -12.2%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
自由媒体集团是1991年由约翰·C·马龙创立的美国大众传媒企业,集团目前按不同追踪股票划分业务板块,持有一级方程式集团和Live Nation娱乐的股权,截至2025年,集团共拥有一级方程式、MotoGP以及世界超级摩托车锦标赛三大全球赛车运动业务。
LAB vs OLP — 直观对比
营收规模更大
OLP
是对方的1.3倍
$19.6M
营收增速更快
OLP
高出15.2%
-11.5%
净利率更高
OLP
高出187.1%
-177.4%
两年增速更快
OLP
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $24.7M |
| 净利润 | $-34.7M | $2.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 28.6% |
| 净利率 | -177.4% | 9.7% |
| 营收同比 | -11.5% | 3.7% |
| 净利润同比 | -28.8% | -77.1% |
| 每股收益(稀释后) | $-0.09 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
OLP
| Q4 25 | — | $24.7M | ||
| Q3 25 | $19.6M | $23.8M | ||
| Q2 25 | $21.8M | $24.5M | ||
| Q1 25 | $40.8M | $24.2M | ||
| Q4 24 | — | $23.9M | ||
| Q3 24 | $22.1M | $22.2M | ||
| Q2 24 | $22.5M | $21.8M | ||
| Q1 24 | $45.5M | $22.7M |
净利润
LAB
OLP
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-34.7M | $10.5M | ||
| Q2 25 | $-33.5M | $8.4M | ||
| Q1 25 | $-26.0M | $4.2M | ||
| Q4 24 | — | $10.6M | ||
| Q3 24 | $-26.9M | $5.2M | ||
| Q2 24 | $-45.7M | $9.6M | ||
| Q1 24 | $-32.2M | $5.2M |
毛利率
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率
LAB
OLP
| Q4 25 | — | 28.6% | ||
| Q3 25 | -168.5% | 66.7% | ||
| Q2 25 | -118.1% | 62.6% | ||
| Q1 25 | -80.8% | 39.8% | ||
| Q4 24 | — | 65.0% | ||
| Q3 24 | -120.9% | 45.0% | ||
| Q2 24 | -134.5% | 66.0% | ||
| Q1 24 | -132.2% | 44.1% |
净利率
LAB
OLP
| Q4 25 | — | 9.7% | ||
| Q3 25 | -177.4% | 44.1% | ||
| Q2 25 | -153.7% | 34.3% | ||
| Q1 25 | -63.8% | 17.2% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | -122.0% | 23.3% | ||
| Q2 24 | -203.3% | 43.8% | ||
| Q1 24 | -70.6% | 22.7% |
每股收益(稀释后)
LAB
OLP
| Q4 25 | — | $0.10 | ||
| Q3 25 | $-0.09 | $0.48 | ||
| Q2 25 | $-0.09 | $0.39 | ||
| Q1 25 | $-0.07 | $0.18 | ||
| Q4 24 | — | $0.49 | ||
| Q3 24 | $-0.07 | $0.23 | ||
| Q2 24 | $-0.12 | $0.45 | ||
| Q1 24 | $-0.27 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $14.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $299.6M |
| 总资产 | $539.6M | $857.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LAB
OLP
| Q4 25 | — | $14.4M | ||
| Q3 25 | $129.4M | $18.8M | ||
| Q2 25 | $158.6M | $19.0M | ||
| Q1 25 | $150.9M | $8.2M | ||
| Q4 24 | — | $42.3M | ||
| Q3 24 | $210.6M | $25.7M | ||
| Q2 24 | $269.8M | $35.0M | ||
| Q1 24 | $287.1M | $27.4M |
总债务
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益
LAB
OLP
| Q4 25 | — | $299.6M | ||
| Q3 25 | $399.7M | $305.6M | ||
| Q2 25 | $424.5M | $303.4M | ||
| Q1 25 | $454.6M | $303.2M | ||
| Q4 24 | — | $307.4M | ||
| Q3 24 | $489.3M | $304.2M | ||
| Q2 24 | $510.3M | $307.3M | ||
| Q1 24 | $577.3M | $304.8M |
总资产
LAB
OLP
| Q4 25 | — | $857.6M | ||
| Q3 25 | $539.6M | $802.3M | ||
| Q2 25 | $557.0M | $795.6M | ||
| Q1 25 | $579.6M | $811.7M | ||
| Q4 24 | — | $767.0M | ||
| Q3 24 | $681.5M | $768.8M | ||
| Q2 24 | $708.7M | $759.2M | ||
| Q1 24 | $777.7M | $755.7M |
负债/权益比
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $37.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | 15.54× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势,按日历期对齐
经营现金流
LAB
OLP
| Q4 25 | — | $37.5M | ||
| Q3 25 | $-22.2M | $10.9M | ||
| Q2 25 | $-20.7M | $11.2M | ||
| Q1 25 | $-30.3M | $11.0M | ||
| Q4 24 | — | $39.1M | ||
| Q3 24 | $-27.9M | $10.0M | ||
| Q2 24 | $-39.0M | $8.6M | ||
| Q1 24 | $-62.5M | $8.9M |
自由现金流
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度
LAB
OLP
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率
LAB
OLP
| Q4 25 | — | 15.54× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 1.33× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 3.70× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | — | 1.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
OLP
暂无分部数据